EUVIMEDEUVIMED entdecken
Crossref

Leveraging Synthetic Antibody–DNA Conjugates to Expand the CRISPR-Cas12a Biosensing Toolbox

Elisa Paialunga, Neda Bagheri iD, Marianna Rossetti, Laura Fabiani, Laura Micheli, Alejandro Chamorro-Garcia, Alessandro Porchetta iD

ACS Synthetic Biology · 17.01.2025 · 14 (1) · 171-178

DOI: 10.1021/acssynbio.4c00541 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Synthetic Biology, online erschienen am 02.01.2025. Verfasst von Elisa Paialunga und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Science and Technologies, University of Rome Tor Vergata, Via della Ricerca Scientifica 1, 00133 Rome, Italy. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Biosensing Techniques, DNA, Endodeoxyribonucleases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: European Commission, Ministero dell?Istruzione, dell?Universit? e della Ricerca, Associazione Italiana per la Ricerca sul Cancro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsBiosensing TechniquesDNAEndodeoxyribonucleasesAntibodiesSARS-CoV-2HumansSpike Glycoprotein, CoronavirusCOVID-19SalivaLimit of DetectionBacterial ProteinsCRISPR-Associated ProteinsEnzyme-Linked Immunosorbent AssayImmunoassay

Stichwörter der Autor:innen

CRISPR-Cas12aantibody–DNA conjugatecollateral cleavagefluorescenceimmunoassaytrans-cleavage

Substanzen

DNASpike Glycoprotein, CoronavirusCas12a proteinspike protein, SARS-CoV-2EndodeoxyribonucleasesAntibodiesBacterial ProteinsCRISPR-Associated Proteins

Autor:innen und Institutionen

  • Department of Chemical Science and Technologies, University of Rome Tor Vergata, Via della Ricerca Scientifica 1, 00133 Rome, Italy.

ORCID-Profile: Neda Bagheri, Alessandro Porchetta

Förderung

  • European Commission
  • Ministero dell?Istruzione, dell?Universit? e della Ricerca
  • Associazione Italiana per la Ricerca sul Cancro
  • Fondazione Umberto Veronesi

Zitieren

APA

Paialunga, E., Bagheri, N., Rossetti, M., Fabiani, L., Micheli, L., Chamorro-Garcia, A., & Porchetta, A. (2025). Leveraging Synthetic Antibody–DNA Conjugates to Expand the CRISPR-Cas12a Biosensing Toolbox. ACS Synthetic Biology, 14(1), 171-178. https://doi.org/10.1021/acssynbio.4c00541

Vancouver

Paialunga E, Bagheri N, Rossetti M, Fabiani L, Micheli L, Chamorro-Garcia A, et al. Leveraging Synthetic Antibody–DNA Conjugates to Expand the CRISPR-Cas12a Biosensing Toolbox. ACS Synthetic Biology. 2025;14(1):171-178. doi:10.1021/acssynbio.4c00541

BibTeX
@article{Paialunga2025,
  author = {Paialunga, Elisa and Bagheri, Neda and Rossetti, Marianna and Fabiani, Laura and Micheli, Laura and Chamorro-Garcia, Alejandro and Porchetta, Alessandro},
  title = {Leveraging Synthetic Antibody–DNA Conjugates to Expand the CRISPR-Cas12a Biosensing Toolbox},
  journal = {ACS Synthetic Biology},
  year = {2025},
  volume = {14},
  number = {1},
  pages = {171--178},
  doi = {10.1021/acssynbio.4c00541}
}
Kostenlos starten →